Significance of serum adiponectin levels in patients with chronic liver disease
about
Biomarkers in nonalcoholic fatty liver diseaseAdiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosisSerum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresiaMolecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin.Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients.The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.The promoting effect of adiponectin in hepatocellular carcinoma.Adipokines in Liver Cirrhosis.Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis.Assessment of metabolic syndrome in patients with primary biliary cirrhosis.Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradox.Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection.Adiponectin as a novel biomarker for liver fibrosis
P2860
Q28080541-B60B7DB5-85A2-4E3B-BA2C-94C7333118D8Q28584013-32F6BB3A-3BD0-4964-A4B3-5B1F8ECF6556Q33831119-4643C0A9-C6CE-4539-84BC-F471C8BC84B9Q34787288-3ECD804F-DAC2-40FC-8BCC-11AA864B8880Q34942815-3928C349-FC66-4299-B7F2-7E1C7C09F1B9Q37581457-13336294-C11A-4BC7-8A2E-65455D8CC446Q39138286-05A292BD-D27F-47BC-BCB5-BC01A6EE38EFQ39262148-36C30756-2D9A-40FD-8E84-99B7D7D8B6C4Q39404632-FDA4D295-67D0-47FB-9666-809FFB7C4CD1Q39404643-A16598C8-3D17-49DE-A567-8C00228E8CCFQ43671252-0BD08E42-1146-40F3-B035-45580B33B9C4Q43960965-B7182BC9-6D60-4C44-8950-BF53D3ECAEEFQ44208724-75460CED-08E5-4331-A460-1A2537E87610Q44900576-F4E8EB77-D86C-46E2-B5DB-006954258C46Q45366869-4DDCFF5E-42A9-4F56-A7E2-901AE3E518C5Q58603859-A542217B-7009-45DD-92A3-F7DB5B635E78
P2860
Significance of serum adiponectin levels in patients with chronic liver disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Significance of serum adiponectin levels in patients with chronic liver disease
@ast
Significance of serum adiponectin levels in patients with chronic liver disease
@en
Significance of serum adiponectin levels in patients with chronic liver disease
@nl
type
label
Significance of serum adiponectin levels in patients with chronic liver disease
@ast
Significance of serum adiponectin levels in patients with chronic liver disease
@en
Significance of serum adiponectin levels in patients with chronic liver disease
@nl
prefLabel
Significance of serum adiponectin levels in patients with chronic liver disease
@ast
Significance of serum adiponectin levels in patients with chronic liver disease
@en
Significance of serum adiponectin levels in patients with chronic liver disease
@nl
P2093
P2860
P356
P1433
P1476
Significance of serum adiponectin levels in patients with chronic liver disease
@en
P2093
Alain Schoepfer
Felix Stickel
Jean-François Dufour
Jeannine Joneli
Maria Luisa Balmer
Wolfgang Thormann
P2860
P304
P356
10.1042/CS20100008
P407
P577
2010-08-05T00:00:00Z